QSS
MRTX

Quantitative Systematic Strategies’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Quantitative Systematic Strategies’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,627
Closed -$586K – 403
2021
Q2 		$586K Sell
3,627
-3,903
-52% -$627K 0.2% 190
2021
Q1 		$1.29M Buy
7,530
+299
+4% +$59.2K 0.2% 166
2020
Q4 		$1.59M Sell
7,231
-136
-2% -$29.4K 0.22% 150
2020
Q3 		$1.22M Sell
7,367
-5,042
-41% -$690K 0.21% 148
2020
Q2 		$1.42M Buy
12,409
+6,796
+121% +$659K 0.28% 113
2020
Q1 		$431K Sell
5,613
-396
-7% -$35.5K 0.35% 104
2019
Q4 		$774K Buy
6,009
+1,329
+28% +$128K 0.11% 265
2019
Q3 		$365K Buy
4,680
+2,045
+78% +$192K 0.08% 294
2019
Q2 		$271K Buy
+2,635
New +$205K 0.05% 351
2019
Q1 		– Sell
-9,287
Closed -$394K – 692
2018
Q4 		$394K Buy
9,287
+4,591
+98% +$183K 0.09% 326
2018
Q3 		$221K Buy
4,696
+351
+8% +$19.5K 0.04% 501
2018
Q2 		$214K Buy
+4,345
New +$164K 0.04% 546
2016
Q3 		– Sell
-30,004
Closed -$165K – 524
2016
Q2 		$165K Buy
+30,004
New +$478K 0.08% 355
2016
Q1 		– Sell
-12,830
Closed -$393K – 818
2015
Q4 		$393K Buy
+12,830
New +$453K 0.11% 244

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Quantitative Systematic Strategies's MRTX Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2021, closing a stake of 3,627 shares — an estimated $586K sold.

Quantitative Systematic Strategies first reported a position in MRTX in Q4 2015 and held it in 14 quarters. The position peaked at $1.59M in Q4 2020. 238 funds tracked by Wall St. Rank hold MRTX as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 3,627 Mirati Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $586K.
  • Quantitative Systematic Strategies first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2015 and held it in 14 quarters.
  • Quantitative Systematic Strategies's Mirati Therapeutics, Inc. Common Stock position peaked at $1.59M in Q4 2020.
  • 238 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.